TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Klerfalk Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
68
|
96
|
102 |
| Financial expenses |
23
|
267
|
48 |
| Earnings before taxes |
-18
|
15
|
-31 |
| EBITDA |
-12
|
7
|
15 |
| Total assets |
988
|
1,055
|
1,046 |
| Current assets |
35
|
60
|
109 |
| Current liabilities |
19
|
33
|
42 |
| Equity capital |
962
|
1,012
|
992 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
97.4%
|
95.9%
|
94.8% |
| Turnover per employee |
68
|
96
|
102 |
| Profit as a percentage of turnover |
-26.5%
|
15.6%
|
-30.4% |
| Return on assets (ROA) |
0.5%
|
26.7%
|
1.6% |
| Current ratio |
184.2%
|
181.8%
|
259.5% |
| Return on equity (ROE) |
-1.9%
|
1.5%
|
-3.1% |
| Change turnover |
-25
|
-6
|
-45 |
| Change turnover % |
-27%
|
-6%
|
-31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.